NMR (CDCl3) δ 168.4 (CdO), 139.1, 138.2, 138.1, 137.9, 137.5
(each s), 132.1, 131.9, 131.2 (each s), 129.5 (s), 128.4, 128.3, 128.2,
128.13, 128.10, 127.9, 127.8, 127.7, 127.4, 127.3, 127.2 (each d),
82.9, 78.9, 77.4, 77.3, 75.5, 74.6, 71.8, 71.3, 69.6, 68.7, 61.0 (each
t); IR (film, CHCl3) νmax 3062, 3029, 2917, 2865, 2358, 2341, 1712,
1598, 1454, 1392, 1373, 1288, 1261, 1027, 908, 809, 744, 698
cm-1; ES-HRMS found 707.2980, C44H44O7Na requires 707.2985
[M + Na]+.
FIGURE 1. Superimposition of the X-ray crystal structures of 9b and
12. The hydrogen atoms are not shown.
(4R,5R,6R,7R)-Tetrakis(benzyloxy)-3,4,5,6,7,8,10,11,12-non-
ahydro-1H-2,9-benzdioxacyclotetradecin-1-one (9a). Catalytic
hydrogenation of a solution of 24a in ethanol (152 mg in 9 mL,
0.22 mmol, 25 mM) in EtOH over 5% Pd-C using a H-cube flow
reactor (pressure ) 80 bar, temperature ) 60 °C, flow rate ) 1
mL/min) followed by removal of excess ethanol under reduced
pressure and subsequent purification of the residue by chromatog-
raphy (19:1, CH2Cl2-MeOH) gave 9a as a colorless oil (51 mg,
71%): Rf 0.48 (9:1, CH2Cl2-MeOH)); [R]20D -21 (c 0.94, CHCl3);
1H NMR (600 MHz, CD3OD) δ 7.81 (d, 1H, J 7.8 Hz), 7.49 (t,
1H, J 7.5 Hz), 7.39 (d, 1H, J 7.8 Hz), 7.30 (t, 1H, J 7.6 Hz), 4.66
(dd, 1H, J 11.4, 2.2 Hz), 4.49 (dd, 1H, J 7.7, 3.3 Hz), 4.46 (dd,
1H, J 11.4, 4.8 Hz), 4.13 (m, 1H), 4.04 (t, 1H, J 3.0 Hz), 3.93 (m,
1H), 3.71 (dd, 1H, J 9.4, 7.0 Hz), 3.57 (m, 3H), 3.21 (dt, 1H, J
14.5, 8.3 Hz), 3.10 (m, 1H), 1.90 (m, 2H); 13C NMR (400 MHz,
CD3OD) δ 170.9 (CdO), 143.5 (s), 133.1 (d), 132.1 (s), 131.9,
131.3, 127.0, 74.1 (each d), 72.8 (t), 72.6 (d), 71.8 (t), 71.7 (d),
71.0 (d), 67.3 (t), 33.0 (t), 32.2 (t); IR (film, CH3OH) νmax 3386,
2921, 2871, 2360, 2341, 1704, 1600, 1446, 1371, 1284, 1263, 1132,
1076, 860, 750 cm-1; ES-HRMS found 349.1259, C16H22O7Na
requires 349.1263 [M + Na]+.
1
TABLE 1. Selected H--H Vicinal Coupling Constants (Hz) for
Oxamacrolidesa
9a
9b
9c
10
12
J3a,4
J3b,4
J4,5
J5,6
J6,7
2.1 (68)
4.7 (51)
7.8 (167)
3.2 (66)
3.2 (68)
7.1 (49)
n.d. (68)
2.2
4.8
7.7
3.2
3.2
7.0
n.d.
2.1
4.6
7.8
3.6
2.8
7.1
n.d
1.8
3.2
9.0
2.3
2.3
n.d
2.9
2.4 (62)
4.6 (58)
7.8 (177)
1.2 (67)
8.6 (161)
6.1 (49)
2.6 (69)
J7,8a
J7,8b
a Dihedral angles (deg) measured using Macromodel 8.5 from the X-ray
crystal structures of 9a and 12 are provided in parentheses.
(4R,5R,6R,7R)-Tetrahydroxy-3,4,5,6,7,8,10-heptahydro-(11E)-
1H-2,9-benzodioxacyclotetradecin-1-one (10). To a solution of
(4R,5R,6R,7R)-tetrakis(methoxymethoxy)-3,4,5,6,7,8,10-heptahydro-
(11E)-1H-2,9-benzodioxacyclotetradecin-1-one (53 mg, 0.11 mmol)
in MeOH (10.6 mL, 0.01 M solution of the precursor) was added
at room temperature concd HCl (1.05 mL). The reaction mixture
was stirred at that temperature for 19 h, the solvent then removed,
and the residue purified by chromatography (19:1, CH2Cl2-MeOH)
analysis indicates the macrolides adopt structures in the solid
state which are similar to that in solution. A preliminary
screening of the hydroxylated products against a panel of 45
kinases has shown that they are not potent inhibitors of kinases,
and suggests that structures based on a resorcyclic acid or
salicylic acid, as suggested by one reviewer, might be required
for potent compounds. The synthesis of salicylic acid analogues
is currently being investigated as are efforts to apply saccha-
ride-macrolide scaffolds to the identification of novel lead
compounds or provision of tools for biological research, and
the outcomes of this research will be reported in due course.
to afford the title compound 10 as a colorless oil (12 mg, 35%):
1
Rf 0.39 (9:1, CH2Cl2-MeOH); [R]20 -23 (c 0.61, CH3OH); H
D
NMR (500 MHz, CD3OD) δ 7.85 (dd, 1H, J 8.1, 1.3 Hz), 7.61
(dd, 1H, J 7.9, 1.1 Hz), 7.50 (ddd, 1H, J 15.2, 1.4, 0.5 Hz), 7.48
(dt, 1H, J 15.3, 1.9 Hz), 7.33 (td, 1H, J 7.6, 1.2 Hz), 6.23 (ddd,
1H, J 16.0, 4.3, 4.0 Hz), 4.77 (dd, 1H, J 9.0, 2.3 Hz), 4.60 (dd,
1H, J 11.5, 1.8 Hz), 4.51 (dd, 1H, J 11.5, 3.2 Hz), 4.29 (dq, 1H, J
14.5, 1.9 Hz), 4.20 (ddd, 1H, J 14.5, 4.5, 2.0 Hz), 4.13 (m, 1H),
4.11 (t, 1H, J 2.3 Hz), 3.87 (m, 2H), 3.66 (dd, 1H, J 10.5, 2.9 Hz);
13C NMR (CD3OD) δ 170.5 (CdO), 139.1 (s), 133.3 (s), 132.3
(d), 131.2 (d), 130.8 (d), 129.6 (d), 128.3 (d), 128.0 (d), 75.7 (d),
73.2 (t), 71.7 (d), 71.5 (t), 71.2 (d), 70.8 (d), 67.8 (t); IR (film,
CH3OH) νmax 3342, 2915, 2861, 2362, 2329, 1702, 1598, 1477,
1448, 1371, 1292, 1268, 1176, 1133, 1079, 1045, 966, 929, 836,
742, 561 cm-1; ES-HRMS found 323.1145, C16H19O7 requires
323.1131 [M - H]-.
Experimental Section
(4R,5R,6R,7R)-Tetrakis(benzyloxy)-3,4,5,6,7,8,10-heptahydro-
(11E)-1H-2,9-benzodioxacyclotetradecin-1-one (24a). To a de-
gassed solution of 23a (384 mg, 0.54 mmol) and 2,6-dichloro-1,4-
benzoquinone (38 mg, 0.22 mmol) in dry toluene (269 mL, 2 mM
solution of 23a) was added Grubbs’catalyst II generation (43 mg,
0.05 mmol) under N2. The reaction mixture was heated and stirred
at 80 °C for 18 h. The solution was then filtered through silica and
washed with diethyl ether, and the solvent was removed. The residue
was purified by chromatography (9:1 cyclohexane-EtOAc) to give
24a (311 mg, 84%, colorless oil): Rf 0.48 (4:1 cyclohexane-
EtOAc); [R]20D -11 (c 0.545, CHCl3); 1H NMR (500 MHz, CDCl3)
δ 7.88 (d, 1H, J 5.8 Hz), 7.47-7.04 (m, 24H), 6.08 (d, 1H, J 13.9
Hz), 5.00 (m, 1H), 4.86 (d, 1H, J 10.4 Hz), 4.72 (m, 3H), 4.47 (m,
Acknowledgment. This investigation was supported by
Science Foundation Ireland (03/IBN/B352) and the Programme
for Research in Third Level Institutions administered by the
HEA. We thank Dr. D. Rai for mass spectrometry, Dr. H.
Mu¨ller-Bunz for X-ray crystal structure determination, and Dr.
J. Muldoon and the UCD NMR Centre for high-field NMR.
3H), 4.38-4.03 (m, 5H), 4.03 (d, 1H, J 7.3 Hz), 3.70 (m, 2H); 13
C
Supporting Information Available: Full experimental proce-
dures, 1H and 13C NMR spectra, NMR assignments, X-ray
structures, and crystallographic information files. This material is
(30) The networks of hydrogen bonding can be viewed using the
crystallographic information files (see the Supporting Information). For
selected publications where hydrogen bonding networks have been of
interest, see (a) Jeffrey, G. A.; Saenger, W. Hydrogen bonding in biological
structures; Springer-Verlag: Berlin, 1991. (b) Murphy, P. V.; Mueller-
Bunz, H.; Velasco-Torrijos, T. Carbohydr. Res. 2005, 340, 1437.
JO062159L
1806 J. Org. Chem., Vol. 72, No. 5, 2007